Psoriasis is one of the most common chronic inflammatory skin diseases, affecting around 250,000 people in Austria. While previous treatment approaches have mainly focused on inhibiting ...
British Association of Dermatologists Biologic Interventions Register (BADBIR) found prior serious infections may outweigh ...
While a health care provider like a dermatologist can diagnose you with psoriasis based on a skin exam and medical history, ...
Newspoint on MSN
Effective home remedies for migraine relief
Understanding Migraine Migraine is a type of headache that typically affects one side of the head, often referred to as a ...
Oruka Therapeutics (NASDAQ:ORKA) is one of the small-cap stocks that are on fire right now. On April 27, Oruka Therapeutics announced positive interim results from its EVERLAST-A Phase 2a trial for ...
Do psoriasis systemic treatments raise serious infection risk? Real-world BADBIR data compares therapies and outcomes. Find ...
European Commission approves Bristol Myers Squibb’s Sotyktu for the treatment of active psoriatic arthritis in adults: Princeton, New Jersey Monday, May 11, 2026, 15:00 Hrs [IST ...
Tildrakizumab maintained efficacy and safety in obese patients with scalp psoriasis over 52 weeks. Find out more about the ...
In the pivotal Phase 3 POETYK PsA clinical trials, Sotyktu demonstrated superiority compared with placebo at Week 16 across multiple endpoints, including skin and joint symptoms, with improvements ...
Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the publication of the original research article titled "Efficacy and Safety of Imsidolimab for Generalized Pustular Psoriasis" in New ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results